Latest News & Features
Patents
The patent landscape for biologics, biosimilars, and advanced therapeutic antibodies is undergoing rapid change, presenting both opportunities and challenges for innovators and manufacturers. This panel will explore current issues and strategies in this dynamic field. 29 October 2024
Patents
Korean pharmaceutical, biotech, and life sciences companies are actively expanding globally, leading to more complex and multifaceted IP strategies than in the past. 29 October 2024
Patents
Join us as we delve into the complexities of international harmonization and global patent strategies in the ever-evolving landscape of IP rights. 29 October 2024
Patents
The dynamic landscape of patent law is continually influenced by evolving regulations and legal decisions, and one of the key areas at the forefront of these changes is the Patent Trial and Appeal Board (PTAB). 29 October 2024
Patents
How to foster effective collaboration between academia and industry?
Best practices for bridging that gap between the two spheres
Technology transfer
How to leverage academic research for commercialization 29 October 2024
Patents
The integration of cutting-edge medical technology within the life sciences has ushered in an era of unprecedented innovation, transforming the landscape of healthcare and patient wellbeing. 29 October 2024
Patents
Obviousness-type double patenting can pose a significant challenge, as it can lead to unfair extensions of patent rights, and limit other’s abilities to build upon inventions, hindering further innovation. 29 October 2024
Patents
In today's global marketplace, intellectual property (IP) rights are not merely legal tools but strategic assets that can significantly influence a product's lifecycle, from development to market. 29 October 2024
Patents
In the world of intellectual property, securing patents for innovative ideas rests heavily on the criteria of novelty, non-obviousness, and the inventive step. 29 October 2024
Patents
In an incredibly competitive and complex landscape, intellectual property is a critical asset for pharmaceutical and biotech companies. 29 October 2024
Not finding what you're looking for, please try resetting your applied search and filters,
or try the full site search.